Patent is Filed on Shrink Nanotechnologies' CellAlign Advanced Tissue Engineering Platform Technology

Published: Sep 17, 2010

CARLSBAD, Calif.--(BUSINESS WIRE)--Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.

Back to news